EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cancer detection using human papillomavirus self‐sampling targeting long‐term non‐attenders in an organized cervical screening program

K Miriam Elfström iD, Maria Hortlund, Daniel Öhman, Joakim Dillner iD

International Journal of Cancer · 2026

DOI: 10.1002/ijc.70321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von K Miriam Elfström und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cervical Cancer Elimination, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Early Detection of Cancer, Uterine Cervical Dysplasia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Association of Local Authorities and Regions and the Stockholm County Council, NordForsk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Self‐sampling for human papillomavirus (HPV) is an established strategy to increase participation in cervical screening. We previously reported a randomized trial targeting women who had not attended screening after >10 invitations, where sending of self‐sampling kits resulted in a 19% attendance and a positive predictive value (PPV) for high grade lesions (HSIL+) of 40%, despite no triaging after the HPV test. Because of the striking results, the intervention was extended to all women resident in Stockholm County, Sweden, in the years 2019/20, who had not attended screening >10 years ( N = 42,409). Participation was 35.6% and 11.6% of the participating women were HPV‐positive. Among these, there were 43 cases of invasive cervical cancer and 319 cases of high‐grade lesions. The PPV was particularly high for HPV16/18 positive women (12% for invasive cancer and 59% for HSIL). In summary, participation with HPV self‐sampling among long‐term non‐attenders in the real‐life program was considerably higher than in the research setting and the high yield of HSIL+ implied high effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsEarly Detection of CancerUterine Cervical DysplasiaPapillomaviridaeHumansFemaleMiddle AgedAdultSwedenSelf CareVaginal SmearsSpecimen HandlingAgedMass ScreeningHuman Papillomavirus Viruses

Stichwörter der Autor:innen

HPVcancerhuman papillomavirusscreeningself‐sampling

Autor:innen und Institutionen

  • Center for Cervical Cancer Elimination, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
  • Unit for Cancer Screening, Regional Cancer Center of Stockholm-Gotland, Stockholm, Sweden.

ORCID-Profile: K Miriam Elfström, Joakim Dillner

Förderung

  • Swedish Association of Local Authorities and Regions and the Stockholm County Council
  • NordForsk

Zitieren

APA

Elfström, K. M., Hortlund, M., Öhman, D., & Dillner, J. (2026). Cancer detection using human papillomavirus self‐sampling targeting long‐term non‐attenders in an organized cervical screening program. International Journal of Cancer. https://doi.org/10.1002/ijc.70321

Vancouver

Elfström KM, Hortlund M, Öhman D, Dillner J. Cancer detection using human papillomavirus self‐sampling targeting long‐term non‐attenders in an organized cervical screening program. International Journal of Cancer. 2026. doi:10.1002/ijc.70321

BibTeX
@article{Elfstrm2026,
  author = {Elfström, K Miriam and Hortlund, Maria and Öhman, Daniel and Dillner, Joakim},
  title = {Cancer detection using human papillomavirus self‐sampling targeting long‐term non‐attenders in an organized cervical screening program},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70321}
}
Kostenlos starten →